• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain

byPaary BalakumarandAlex Chan
August 15, 2025
in Chronic Disease, Orthopedic Surgery, Rheumatology
Reading Time: 2 mins read
Parental nonmedical prescription opioid use linked to adolescent use
Share on FacebookShare on Twitter

1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months, particularly in older patients

2. Pain location and baseline health status are not reliable indicators of whether a patient will continue medical cannabis use.

Evidence Rating Level: 3 (Average)

In this retrospective study, 78 patients with chronic musculoskeletal pain certified for medical cannabis (MC) at a single orthopedic institute between October 2022 and December 2024 were followed for up to one year to assess discontinuation rates and associated factors. Demographics, pain origin, and baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Global Physical Health (GPH) and Global Mental Health (GMH) scores were collected. Discontinuation status was confirmed through follow-up visits and the state MC registry. At three months, 44.7% of patients had discontinued MC, primarily due to dissatisfaction, preference for alternative treatments, or surgical intervention. By one year, 57.9% had ceased use, with older age significantly associated with discontinuation (mean 71.5 vs. 64.5 years; p = 0.04). Pain origin, including low back pain, did not significantly differ between those continuing and discontinuing, and baseline GPH/GMH scores were similar in both groups. These findings suggest that over half of patients stop MC within a year, with older adults more likely to discontinue, and that baseline health status and pain location are not strong predictors of adherence. Further research is warranted to identify modifiable factors that could improve long-term MC use for chronic musculoskeletal pain.

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

2 Minute Medicine Rewind September 14, 2026

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: cannabischronic painmskmusculoskeletal painpain
Previous Post

#VisualAbstract: Riociguat Improves Exercise Following Balloon Pulmonary Angioplasty in Patients with Pulmonary Hypertension

Next Post

2 Minute Medicine Rewind August 18, 2025

RelatedReports

Imaging and Intervention

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

September 18, 2026
Chronic Disease

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

September 17, 2026
Weekly Rewinds

2 Minute Medicine Rewind September 14, 2026

September 14, 2026
Epidural corticosteroid injections provide only short-term radiculopathy pain relief
Chronic Disease

A neurostimulation intervention may improve pain in patients with chronic low back pain

August 17, 2026
Next Post
Few high school students, young adults get HIV testing

2 Minute Medicine Rewind August 18, 2025

Tramadol use linked with increased risk of hypoglycemia hospitalizations

Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • High maternal egg-peanut intake not associated with reduced infant allergy
  • The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children
  • Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.